Archives
D-Mannitol: Identity and Evidence Scope
D-Mannitol is identified in the supplied product information as a solid compound with the formula C6H14O6, a stated molecular weight of 182.17, and the stereochemical name (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol. APExBIO describes the material as a biochemical reagent and reports 98% purity with quality-control support from mass spectrometry and nuclear magnetic resonance analyses. These details document the marketed product’s identity and characterization claims; they do not independently establish biological activity or research performance.
Conceptual scope
The supplier describes D-Mannitol as an osmotic diuretic agent and associates it with osmotic regulation research, renal function studies, and diuretic mechanism investigation. In conceptual terms, these areas concern how a defined small molecule may be examined in relation to solute-driven water movement, renal handling, and diuretic physiology. The supplied information also mentions weak renal vasodilator properties, but no matched study was provided to verify that characterization, quantify an effect, or establish its relevance across models.
Evidence availability
No specific reference paper, study identifier, comparator, outcome dataset, or independent validation was supplied for product SKU B2090. Consequently, the available evidence does not support claims about efficacy, mechanism, reproducibility, safety, or disease-related outcomes. In particular, the product description cannot by itself establish applicability to kidney disease research, clinical treatment, or any specific renal condition. The related articles supplied as context repeat product-level descriptions but do not provide a documented matched study and therefore do not close this evidence gap.
Applicability boundaries
The defensible conclusion is limited to documented product identity and a supplier-defined conceptual research scope. Physical-property and quality-control statements are not substitutes for peer-reviewed pharmacology, comparative renal studies, or clinical evidence. No conclusion should be drawn from the available materials about how D-Mannitol performs in a particular experimental model, whether it produces a specified renal or vascular outcome, or whether findings would generalize from research settings to patients.